logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > (S)-2-((2-oxo-3-(4-(3-oxoMorpholino)phenyl)oxazolidin-5-yl)Methyl)isoindoline-1,3-dione CAS 446292-08-6

(S)-2-((2-oxo-3-(4-(3-oxoMorpholino)phenyl)oxazolidin-5-yl)Methyl)isoindoline-1,3-dione CAS 446292-08-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 446292-08-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
446292-08-6
Appearance ::
White To Off-white Power
Molecular Formula::
C22H19N3O6
Molecular Weight::
421.403
EINECS NO::
610-201-0
MDL NO::
MFCD11977664
CAS NO::
446292-08-6
Appearance ::
White To Off-white Power
Molecular Formula::
C22H19N3O6
Molecular Weight::
421.403
EINECS NO::
610-201-0
MDL NO::
MFCD11977664
(S)-2-((2-oxo-3-(4-(3-oxoMorpholino)phenyl)oxazolidin-5-yl)Methyl)isoindoline-1,3-dione CAS 446292-08-6

Product Description:

Product Name: (S)-2-((2-oxo-3-(4-(3-oxoMorpholino)phenyl)oxazolidin-5-yl)Methyl)isoindoline-1,3-dione CAS NO:446292-08-6

 

 

 

 

 

 

 

 

Synonyms:

4-[4-[(5S)-5-Phthalimidomethyl-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone;

 

 

 

 

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance : White to off-white power

Assay :≥99.0%

Density:1.47g/cm3

Boiling Point:702.9℃ at 760 mmHg

Flash Point:378.9℃

 

 

 

 

 

 

 

 

 

 

It is an intermediate of Rivaroxaban.

Rivaroxaban has been approved for use in adult patients with hip or knee replacement surgery to prevent venous thrombosis (VTE); and to treat adult deep vein thrombosis (DVT) to reduce DVT recurrence and pulmonary embolism after acute DVT ( PE) risk.

 

 

 

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.